BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 19696642)

  • 41. Role of Computed Tomography Volumetry in Estimating Liver Weights in Surgical Patients with Hepatic Steatosis.
    Ha Y; Shim JH; Song GW; Kim SO; Ha TY; Jung DH; Kim KM; Lim YS; Lee HC; Lee SG
    Exp Clin Transplant; 2017 Apr; 15(2):196-202. PubMed ID: 28338460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is Unenhanced Computed Tomography Reliable in the Assessment of Macrovesicular Steatosis in Living Liver Donors?
    Haberal KM; Turnaoğlu H; Haberal Reyhan AN
    Exp Clin Transplant; 2019 Dec; 17(6):749-752. PubMed ID: 31666000
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of steatotic graft in living-donor liver transplantation.
    Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
    Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative Evaluation of Liver Parenchyma of Potential Donors in Living Donor Liver Transplantation.
    Novruzov N; Bayramov N; Mammadov E
    Transplant Proc; 2019 Sep; 51(7):2379-2382. PubMed ID: 31474295
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Obesity-Induced Hepatic Steatosis Is Partly Mediated by Visceral Fat Accumulation in Subjects with Overweight/Obesity: A Cross-Sectional Study.
    Liu F; Chen S; Li X; Li S; Xiao Y; Han J; Tu Y; Bao Y; Bai W; Yu H
    Obes Facts; 2023; 16(2):164-172. PubMed ID: 36257286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat.
    Iacobellis G; Pellicelli AM; Grisorio B; Barbarini G; Leonetti F; Sharma AM; Barbaro G
    Obesity (Silver Spring); 2008 Jan; 16(1):179-83. PubMed ID: 18223632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microvesicular liver graft steatosis as a risk factor of initial poor function in relation to suboptimal donor parameters.
    Cieślak B; Lewandowski Z; Urban M; Ziarkiewicz-Wróblewska B; Krawczyk M
    Transplant Proc; 2009 Oct; 41(8):2985-8. PubMed ID: 19857657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mild hepatic steatosis is not a major risk factor for hepatectomy and regenerative power is not impaired.
    Cho JY; Suh KS; Kwon CH; Yi NJ; Lee KU
    Surgery; 2006 Apr; 139(4):508-15. PubMed ID: 16627060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
    Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
    Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Visceral adiposity as a risk factor for lean non-alcoholic fatty liver disease in potential living liver donors.
    Lee S; Kim KW; Lee J; Park T; Khang S; Jeong H; Song GW; Lee SG
    J Gastroenterol Hepatol; 2021 Nov; 36(11):3212-3218. PubMed ID: 34169561
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD.
    Shannon A; Alkhouri N; Carter-Kent C; Monti L; Devito R; Lopez R; Feldstein AE; Nobili V
    J Pediatr Gastroenterol Nutr; 2011 Aug; 53(2):190-5. PubMed ID: 21788761
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of CT methods for determining graft steatosis in living donor liver transplantation.
    Şeker M; Erol C; Sevmiş Ş; Saka B; Durur Karakaya A
    Abdom Radiol (NY); 2019 Jul; 44(7):2418-2429. PubMed ID: 30937504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis.
    Meffert PJ; Baumeister SE; Lerch MM; Mayerle J; Kratzer W; Völzke H
    Am J Gastroenterol; 2014 Sep; 109(9):1404-14. PubMed ID: 24957156
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Liver steatosis assessment: correlations among pathology, radiology, clinical data and automated image analysis software.
    Lee MJ; Bagci P; Kong J; Vos MB; Sharma P; Kalb B; Saltz JH; Martin DR; Adsay NV; Farris AB
    Pathol Res Pract; 2013 Jun; 209(6):371-9. PubMed ID: 23707550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors.
    Tran TT; Changsri C; Shackleton CR; Poordad FF; Nissen NN; Colquhoun S; Geller SA; Vierling JM; Martin P
    J Gastroenterol Hepatol; 2006 Feb; 21(2):381-3. PubMed ID: 16509862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MRI in identifying hepatic steatosis in obese children and relation to ultrasonography and metabolic findings.
    Pozzato C; Radaelli G; Dall'Asta C; Verduci E; Villa A; Villa C; Scaglioni S; Riva E; Pontiroli AE; Cornalba G; Giovannini M
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):493-9. PubMed ID: 18852643
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hypoadiponectinemia plays a crucial role in the development of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus independent of visceral adipose tissue.
    Yoneda M; Iwasaki T; Fujita K; Kirikoshi H; Inamori M; Nozaki Y; Maeyama S; Wada K; Saito S; Terauchi Y; Nakajima A
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S15-21. PubMed ID: 17331160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation.
    Oshita A; Tashiro H; Amano H; Kobayashi T; Onoe T; Ide K; Takaki S; Takahashi S; Arihiro K; Chayama K; Ohdan H
    Transplantation; 2012 May; 93(10):1024-30. PubMed ID: 22495493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Relationship between liver controlled attenuation parameters and body fat mass and its distribution].
    Shao YL; Zhang SC; Wu JM; Guo FC; Liu LG; Ye CY; Yan T; Cao Q; Zhang F; Wang J; Mao YH; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2019 Oct; 27(10):754-759. PubMed ID: 31734988
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.